MEDICINOVA, INC. (MNOV)

Every figure this model derived for MNOV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 13,724 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 65,398,134 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 25,921,426 AssetsCurrent 2026-06-30
current liabilities 2,961,075 LiabilitiesCurrent 2026-06-30
equity 37,270,602 StockholdersEquity 2026-06-30
ocf -9,110,256 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 920,481 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 922,783 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MNOV on one particular measure came for.

RatioValue
cash operating margin-1185.08
current ratio8.75
current ratio reported8.75
deferred revenue growth-100.0
dilution pct0.04
fcf margin-991.22
growth cv1.74
operating margin-1287.41
owner earnings margin-1091.47
sbc pct revenue100.25

What to be careful about

What this model itself distrusts about MNOV's figures. Written by the derivation as it ran, not added afterwards.